Table 5.
Univariate and Multivariate analysis of PFS
Cases | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
1-yr survival rate(%) | 2-yr survival rate(%) | Median survival(mo) | P-Value | ExpB (Hazard Ratio ,95 % CI) | P-Value | ||
Gender | |||||||
Male | 130 | 47 | 26 | 10.79 | 0.331 | ||
Female | 12 | 37 | 0 | 6.11 | |||
Age | |||||||
< 60 | 92 | 49 | 29 | 10.49 | 0.180 | ||
≥ 60 | 50 | 40 | 21 | 9.35 | |||
Alpha-foetoprotein(ng/ml) | |||||||
≤ 20 | 42 | 50 | 44 | 11.99 | 0.445 | ||
20–400 | 37 | 35 | 8 | 7.03 | |||
≥ 400 | 63 | 51 | 28 | 8.37 | |||
Child Pugh grade | 0.047 | 2.852(1.002–8.293) | 0.050 | ||||
A | 133 | 48 | 28 | 10.56 | |||
B | 9 | 22 | 0 | 7.07 | |||
ALB(g/L) | 0.307 | ||||||
≥ 35 | 108 | 46 | 20 | 10.49 | |||
< 35 | 34 | 47 | 47 | 10.25 | |||
Tbil(U/L) | 0.429 | ||||||
< 20 | 104 | 49 | 23 | 11.18 | |||
≥ 20 | 38 | 37 | 32 | 6.21 | |||
Platelet count (10E9/L) | |||||||
< 100 | 19 | 74 | 32 | 13.57 | 0.144 | ||
≥ 100 | 123 | 42 | 25 | 9.83 | |||
No. of tumours | 0.034 | 3.992(1.978–8.057) | 0.001 | ||||
≤ 3 | 118 | 51 | 28 | 11.04 | |||
> 3 | 24 | 21 | 14 | 7.6 | |||
Tumour size (cm) | 0.988 | 2.667(1.041–6.832) | 0.041 | ||||
≤ 5 | 35 | 39 | 24 | 11.37 | |||
> 5 | 107 | 48 | 25 | 8.37 | |||
Virus infection | 0.079 | ||||||
none | 14 | 59 | 59 | 13.05 | |||
HBV | 126 | 43 | 24 | 10.25 | |||
HCV | 2 | 50 | 0 | 11.30 | |||
Anti-virus therapy | 0.951 | ||||||
Yes | 33 | 44 | 30 | 8.37 | |||
No | 95 | 43 | 22 | 10.56 | |||
H101 | 0.051 | 0.461(0.244–0.870) | 0.017 | ||||
Yes | 74 | 51 | 32 | 10.49 | |||
No | 68 | 41 | 20 | 9.72 |